Announcements Trials

Browse Landscape

Phase

Status

Terminated 3 Completed 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Rituximab 57 Cyclophosphamide 40 Vincristine 26 Prednisone 25 Doxorubicin 22 Cytarabine 18 Lenalidomide 17 Etoposide 17 Gemcitabine 12 Melphalan 8 Filgrastim 8 Cisplatin 8 zanubrutinib 7 Peripheral Blood Stem Cell Transplantation 7 Oxaliplatin 7 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Methotrexate 7 Ifosfamide 7 Carmustine 7 R-CHOP protocol 6 fludarabine phosphate 5 Vindesine 5 Radiotherapy 5 Dexamethasone 5 Decitabine 5 Busulfan 5 ibrutinib 4 Methylprednisolone 4 Epirubicin 4 Cyclosporine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Large B-Cell, Diffuse × copanlisib × Clear all

NCT04263584 2024-01-05

COPA-R-CHOP

University Hospital Muenster

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡